Harnessing the heart of big data.

  title={Harnessing the heart of big data.},
  author={Sarah B. Scruggs and K. Watson and Andrew I. Su and Henning Hermjakob and John R. Yates and Merry L. Lindsey and Peipei Ping},
  journal={Circulation research},
  volume={116 7},
The exponential increase in Big Data generation combined with limited capitalization on the wealth of information embedded within Big Data has prompted us to revisit our scientific discovery paradigms. A successful transition into this digital era of medicine holds great promise for advancing fundamental knowledge in biology, innovating human health, and driving personalized medicine; however, this will require a drastic shift of research culture in how we conceptualize science and use data. An… 

Figures from this paper

Application of Big Data Analytics : An Innovation in Health Care

The need of big data in medicine and healthcare is addressed in this article to reduce costs of treatment, predict outbreaks of epidemics, avoid preventable diseases and improve the quality of life in general.

Medical big data: promise and challenges

  • C. LeeH. Yoon
  • Computer Science
    Kidney research and clinical practice
  • 2017
Many challenges, such as the absence of evidence of practical benefits of big data, methodological issues including legal and ethical issues, and clinical integration and utility issues must be overcome to realize the promise of medical big data as the fuel of a continuous learning healthcare system that will improve patient outcome and reduce waste in areas including nephrology.

Big Data in Cardiovascular Disease

The role of big data and AI in cardiovascular disease is defined with a focus on research to profile in this paper an extensive listing of various datasets used throughout the globe to study big data.

Big data, artificial intelligence, and cardiovascular precision medicine

The potential of a big data approaches with emerging technology to explore the heterogeneity of CVDs, as well as the current challenges and future of precision cardiovascular medicine are highlighted.

Big Data and Its Application in Healthcare and Medical Field

A specialist framework through which the specialists and patients can be associated for all intents and purposes is developed which can be used to transform the gathered data (unstructured data) into several diagnostics and predictions for personalized medicine and personalized healthcare options.

Review on Human Reference and Personal Genome Big Data Analysis

The present study reviews on Human Genome big data analytics with the above-mentioned services and methods will insight the bioinformaticians for human genetic variants analysis among individuals and that will pave the way to find personalized medicine for societal benefits.

Operationalizing Precision Cardiovascular Medicine: Three Innovations.

This work proposes a change in the fundamental relationship between basic and clinical science: rather than 2 distinct entities between which concepts must be translated, it envision a natural hybrid of these approaches, wherein discovery science and clinical trials coincide in the same health systems and patient populations.

Big Data Features, Applications, and Analytics in Cardiology—A Systematic Literature Review

This research summarizes and organizes the existing literature based on the defined keywords and research questions to help doctors to make more authentic decisions, which ultimately will help to use the study as evidence for treating patients with heart related diseases.

Big Data for cardiology: novel discovery?

The potential of comprehensive data sets for scientific discovery is examined, and its impact on the scientific method generally and cardiology in particular is posited, together with likely consequences for research and practice.



Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system.

  • H. Krumholz
  • Medicine, Political Science
    Health affairs
  • 2014
The ways in which big data can be harnessed to advance prediction, performance, discovery, and comparative effectiveness research to address the complexity of patients, populations, and organizations are explored.

Integration of Cardiac Proteome Biology and Medicine by a Specialized Knowledgebase

A consolidated cardiac proteome knowledgebase with novel bioinformatics pipeline and Web portals, thereby serving as a new resource to advance cardiovascular biology and medicine and providing an innovative and interactive resource that connects research interests with the new biological discoveries in protein sciences.

Reengineering Translational Science: The Time Is Right

  • F. Collins
  • Medicine
    Science Translational Medicine
  • 2011
The new National Center for Advancing Translational Sciences aims to revamp the process of biomedical research translation to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of diseases and conditions.

Microtask Crowdsourcing for Disease Mention Annotation in PubMed Abstracts

The use of the AMT in capturing disease mentions in PubMed abstracts is investigated, using the NCBI Disease corpus as a gold standard for refining and benchmarking the crowdsourcing protocol, and the quality of the annotations, as judged with the F measure, increases with the number of workers assigned to each task.

Clues from the resilient

There are, indeed, individuals whose genetics indicate exceptionally high risk of disease, yet they never show any signs of the disorder; this view underlies “The Resilience Project”, an effort to search broadly for these apparently healthy people.

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data

The first large-scale application of the phenome-wide association study (PheWAS) paradigm within electronic medical records (EMRs) is reported, an unbiased approach to replication and discovery that interrogates relationships between targeted genotypes and multiple phenotypes in EMR-based cohorts.

Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it

Success in turning round drug discovery requires decent systems biology models of human biochemical networks and a return to ‘function‐first’ or phenotypic screening, which should both lower attrition rates and raise the rates of discovery of effective drugs substantially.

Reactome: a database of reactions, pathways and biological processes

A new web site with improved tools for pathway browsing and data analysis is developed, and orthology-based inferences of pathways in non-human species are made, applying Ensembl Compara to identify orthologs of curated human proteins in each of 20 other species.

Personalized medicine: risk prediction, targeted therapies and mobile health technology

In this forum article, specialists in oncology, neurology, endocrinology and mobile health technology are asked to discuss where the authors are in terms of personalized medicine, and address their visions for the future and the challenges that remain in their respective fields.

Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction

Background— Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical syndrome in need of improved phenotypic classification. We sought to evaluate whether unbiased